Jingxian Gu

763 total citations
19 papers, 548 citations indexed

About

Jingxian Gu is a scholar working on Cancer Research, Molecular Biology and Hepatology. According to data from OpenAlex, Jingxian Gu has authored 19 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 7 papers in Molecular Biology and 6 papers in Hepatology. Recurrent topics in Jingxian Gu's work include Cancer-related molecular mechanisms research (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and RNA modifications and cancer (4 papers). Jingxian Gu is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and RNA modifications and cancer (4 papers). Jingxian Gu collaborates with scholars based in China and Hong Kong. Jingxian Gu's co-authors include Jingyao Zhang, Xiaohong Xiang, Runchen Miao, Xing Zhang, Yunong Fu, Kai Qu, Kai Qu, Ting Lin, Xiaohua Ma and Simin Zhang and has published in prestigious journals such as Blood, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Jingxian Gu

18 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingxian Gu China 14 307 262 110 71 61 19 548
Lijun Sun China 13 272 0.9× 103 0.4× 82 0.7× 150 2.1× 107 1.8× 25 610
Dabing Huang China 15 276 0.9× 142 0.5× 39 0.4× 75 1.1× 44 0.7× 30 534
Dongyuan Xu China 13 240 0.8× 150 0.6× 66 0.6× 51 0.7× 52 0.9× 42 516
Jinghui Zheng China 9 230 0.7× 130 0.5× 95 0.9× 34 0.5× 32 0.5× 39 449
Eslam E. Abd El-Fattah Egypt 14 256 0.8× 72 0.3× 58 0.5× 82 1.2× 46 0.8× 18 496
Kechao Nie China 14 261 0.9× 170 0.6× 163 1.5× 28 0.4× 54 0.9× 34 516
Fangfang Gao China 16 264 0.9× 112 0.4× 67 0.6× 51 0.7× 51 0.8× 44 543
Shuai Jin China 11 224 0.7× 152 0.6× 51 0.5× 24 0.3× 39 0.6× 26 407
Hongxiu Han China 13 304 1.0× 179 0.7× 101 0.9× 40 0.6× 55 0.9× 24 630

Countries citing papers authored by Jingxian Gu

Since Specialization
Citations

This map shows the geographic impact of Jingxian Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingxian Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingxian Gu more than expected).

Fields of papers citing papers by Jingxian Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingxian Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingxian Gu. The network helps show where Jingxian Gu may publish in the future.

Co-authorship network of co-authors of Jingxian Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Jingxian Gu. A scholar is included among the top collaborators of Jingxian Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingxian Gu. Jingxian Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
3.
Gu, Jingxian, Sining Liu, Wei Cui, et al.. (2022). Identification of the Predictive Models for the Treatment Response of Refractory/Relapsed B-Cell ALL Patients Receiving CAR-T Therapy. Frontiers in Immunology. 13. 858590–858590. 6 indexed citations
4.
Wang, Xintian, et al.. (2020). Clinical evidence for acupressure with the improvement of sleep disorders in hemodialysis patients: A systematic review and meta-analysis. Complementary Therapies in Clinical Practice. 39. 101151–101151. 14 indexed citations
5.
Ma, Xiaohua, Jingxian Gu, Kun Wang, et al.. (2019). Identification of a molecular subtyping system associated with the prognosis of Asian hepatocellular carcinoma patients receiving liver resection. Scientific Reports. 9(1). 7073–7073. 8 indexed citations
6.
Gu, Jingxian, Xing Zhang, Runchen Miao, et al.. (2019). Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. World Journal of Gastroenterology. 25(2). 220–232. 93 indexed citations
7.
Gu, Jingxian, Xing Zhang, Ruixia Cui, et al.. (2019). Prognostic predictors for patients with hepatocellular carcinoma receiving adjuvant transcatheter arterial chemoembolization. European Journal of Gastroenterology & Hepatology. 31(7). 836–844. 14 indexed citations
8.
Gu, Jingxian, Xing Zhang, Zhixin Wang, et al.. (2019). Simplified nomograms based on platelet-associated models for survival prediction in Asian hepatocellular carcinoma patients after surgery. Surgical Oncology. 30. 131–138. 5 indexed citations
9.
Zhang, Xing, Runchen Miao, Tian Liu, et al.. (2019). IDH1 as a frequently mutated gene has potential effect on exosomes releasement by epigenetically regulating P2RX7 in intrahepatic cholangiocarcinoma. Biomedicine & Pharmacotherapy. 113. 108774–108774. 14 indexed citations
10.
Xiang, Xiaohong, Li Yang, Xing Zhang, et al.. (2019). Seven-senescence-associated gene signature predicts overall survival for Asian patients with hepatocellular carcinoma. World Journal of Gastroenterology. 25(14). 1715–1728. 35 indexed citations
11.
Miao, Runchen, Xing Zhang, Yang He, et al.. (2019). Combined eight-long noncoding RNA signature: a new risk score predicting prognosis in elderly non-small cell lung cancer patients. Aging. 11(2). 467–479. 26 indexed citations
12.
Lin, Ting, Yunong Fu, Xing Zhang, et al.. (2018). A seven-long noncoding RNA signature predicts overall survival for patients with early stage non-small cell lung cancer. Aging. 10(9). 2356–2366. 43 indexed citations
13.
Lin, Ting, Jingxian Gu, Kai Qu, et al.. (2018). A new risk score based on twelve hepatocellular carcinoma-specific gene expression can predict the patients’ prognosis. Aging. 10(9). 2480–2497. 21 indexed citations
15.
Bi, Jianbin, Jingyao Zhang, Simin Zhang, et al.. (2017). Hydrogen-rich water protects against inflammatory bowel disease in mice by inhibiting endoplasmic reticulum stress and promoting heme oxygenase-1 expression. World Journal of Gastroenterology. 23(8). 1375–1375. 32 indexed citations
16.
Cao, Changlin, Jingxian Gu, & Jingyao Zhang. (2017). Soluble triggering receptor expressed on myeloid cell-1 (sTREM-1): a potential biomarker for the diagnosis of infectious diseases. Frontiers of Medicine. 11(2). 169–177. 48 indexed citations
17.
Wan, Yong, Ruixia Cui, Jingxian Gu, et al.. (2017). Identification of Four Oxidative Stress‐Responsive MicroRNAs, miR‐34a‐5p, miR‐1915‐3p, miR‐638, and miR‐150‐3p, in Hepatocellular Carcinoma. Oxidative Medicine and Cellular Longevity. 2017(1). 5189138–5189138. 58 indexed citations
18.
19.
Zhang, Jingyao, Simin Zhang, Jianbin Bi, et al.. (2017). Astaxanthin pretreatment attenuates acetaminophen-induced liver injury in mice. International Immunopharmacology. 45. 26–33. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026